Literature DB >> 20012988

Morphological and immunophenotypic features of primary and metastatic giant cell tumour of bone.

M Alberghini1, K Kliskey, T Krenacs, P Picci, L Kindblom, R Forsyth, N A Athanasou.   

Abstract

Giant cell tumour of bone (GCTB) is a primary tumour of bone that may rarely, in the absence of malignant cytological features, produce metastatic lesions, most commonly in the lungs. Whether these lung nodules represent true neoplastic secondaries or implants derived from the primary tumour is not certain. In this study, we have analysed the morphological and immunophenotypic features of 19 conventional GCTBs and corresponding lung nodules for expression of macrophage, osteoclast, proliferation and tumour-associated markers. A striking morphological feature of all GCTBs that produced lung secondaries was the presence of large areas of haemorrhage and thrombus formation; mononuclear and multinucleated cells of GCTB were frequently found within these areas of haemorrhage and thrombus. A similar pattern of CD14, CD33, HLA-DR and CD51 expression was seen in macrophages and giant cells in primary and secondary tumours. Smooth muscle actin expression was frequently noted in primary GCTBs that recurred and metastasised. No difference was seen in the expression of p53, p63, Ki-67, cyclin D1 or Bcl-2 in primary and secondary tumours. Our findings suggest that most lung nodules associated with primary conventional GCTBs are implants derived from tumour emboli formed in areas of haemorrhage and thrombus formation within the primary tumour.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20012988     DOI: 10.1007/s00428-009-0863-2

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  20 in total

1.  Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue.

Authors:  Yu Sin Lau; Afsaneh Sabokbar; C L M H Gibbons; Henk Giele; Nicholas Athanasou
Journal:  Hum Pathol       Date:  2005-09       Impact factor: 3.466

2.  Immunohistochemical expression of p53, MDM2, Ki-67 and PCNA in central giant cell granuloma and giant cell tumor.

Authors:  P E de Souza; J F Paim; J N Carvalhais; R S Gomez
Journal:  J Oral Pathol Med       Date:  1999-02       Impact factor: 4.253

3.  Molecular analysis of primary and recurrent giant cell tumors of bone.

Authors:  Uma N M Rao; Mark Goodman; Wen-Wei Chung; Patricia Swalski; Raj Pal; Sydney Finkelstein
Journal:  Cancer Genet Cytogenet       Date:  2005-04-15

4.  A case of probable benign pulmonary "metastases" or implants arising from a giant cell tumor of bone.

Authors:  J M Mirra; T Ulich; J Magidson; L Kaiser; J Eckardt; R Gold
Journal:  Clin Orthop Relat Res       Date:  1982 Jan-Feb       Impact factor: 4.176

5.  Analysis of giant cell tumor of bone with pulmonary metastases.

Authors:  S Osaka; M Toriyama; K Taira; S Sano; K Saotome
Journal:  Clin Orthop Relat Res       Date:  1997-02       Impact factor: 4.176

6.  Giant-cell tumor of bone with pulmonary metastases.

Authors:  F Bertoni; D Present; W F Enneking
Journal:  J Bone Joint Surg Am       Date:  1985-07       Impact factor: 5.284

7.  Proliferation index and vascular density of giant cell tumors of bone: are they prognostic markers?

Authors:  M A Sulh; M A Greco; T Jiang; S B Goswami; D Present; G Steiner
Journal:  Cancer       Date:  1996-05-15       Impact factor: 6.860

8.  Cathepsin K is the principal protease in giant cell tumor of bone.

Authors:  Jan H N Lindeman; Roeland Hanemaaijer; Adri Mulder; P D Sander Dijkstra; Károly Szuhai; Dieter Bromme; Jan H Verheijen; Pancras C W Hogendoorn
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

9.  Clinical and immunohistochemical characteristics of benign giant cell tumour of bone with pulmonary metastases: case series.

Authors:  S Osaka; H Sugita; E Osaka; Y Yoshida; J Ryu; A Hemmi; K Suzuki
Journal:  J Orthop Surg (Hong Kong)       Date:  2004-06       Impact factor: 1.118

Review 10.  Benign metastasizing giant-cell tumor of bone. Report of three cases and review of the literature.

Authors:  W J Maloney; L M Vaughan; H H Jones; J Ross; D A Nagel
Journal:  Clin Orthop Relat Res       Date:  1989-06       Impact factor: 4.176

View more
  23 in total

1.  Malignant giant cell tumor of the rib with lung metastasis in a man.

Authors:  Heng Du; Huan Xu; Guowei Che
Journal:  J Thorac Dis       Date:  2014-09       Impact factor: 2.895

Review 2.  Integration of denosumab therapy in the management of giant cell tumors of bone.

Authors:  Daniel T Miles; Ryan T Voskuil; Wood Dale; Joel L Mayerson; Thomas J Scharschmidt
Journal:  J Orthop       Date:  2020-03-28

Review 3.  The clinical approach toward giant cell tumor of bone.

Authors:  Lizz van der Heijden; P D Sander Dijkstra; Michiel A J van de Sande; Judith R Kroep; Remi A Nout; Carla S P van Rijswijk; Judith V M G Bovée; Pancras C W Hogendoorn; Hans Gelderblom
Journal:  Oncologist       Date:  2014-04-09

4.  Smooth muscle actin expression in primary bone tumours.

Authors:  F Hemingway; T G Kashima; G Mahendra; A Dhongre; P C W Hogendoorn; F Mertens; N A Athanasou
Journal:  Virchows Arch       Date:  2012-04-28       Impact factor: 4.064

5.  Differentially expressed genes in giant cell tumor of bone.

Authors:  Erica Babeto; André Luis Giacometti Conceição; Marina Curado Valsechi; Paulo Peitl Junior; Débora Aparecida Pires de Campos Zuccari; Luiz Guilherme Cernaglia Aureliano de Lima; Jane Lopes Bonilha; Marília de Freitas Calmon; José Antônio Cordeiro; Paula Rahal
Journal:  Virchows Arch       Date:  2011-02-09       Impact factor: 4.064

6.  Histological and clinical characteristics of malignant giant cell tumor of bone.

Authors:  Lihua Gong; Weifeng Liu; Xiaoqi Sun; Constantin Sajdik; Xinxia Tian; Xiaohui Niu; Xiaoyuan Huang
Journal:  Virchows Arch       Date:  2012-02-17       Impact factor: 4.064

7.  Recurrence of giant cell tumour of bone: role of p53, cyclin D1, β-catenin and Ki67.

Authors:  Nenad Lujic; Jelena Sopta; Relja Kovacevic; Vladan Stevanovic; Radoslav Davidovic
Journal:  Int Orthop       Date:  2016-09-22       Impact factor: 3.075

8.  A diagnosis of giant cell-rich tumour of bone is supported by p63 immunohistochemistry, when more than 50 % of cells is stained.

Authors:  André Maues De Paula; Alexandre Vasiljevic; Roch Giorgi; Anne Gomez-Brouchet; Sébastien Aubert; Xavier Leroy; Hélène Duval; Gonzague de Pinieux; Corinne Bouvier
Journal:  Virchows Arch       Date:  2014-08-07       Impact factor: 4.064

9.  p63 as a prognostic marker for giant cell tumor of bone.

Authors:  Michiro Yanagisawa; Hiroshi Kakizaki; Kyoji Okada; Tomoaki Torigoe; Tomomi Kusumi
Journal:  Ups J Med Sci       Date:  2012-10-04       Impact factor: 2.384

10.  Cytomorphology of giant cell tumor of bone in pleural fluid.

Authors:  Rajni Yadav; Sameer Bakhshi; Sandeep R Mathur; Tvsvgk Tilak; Geetika Singh; Venkateswaran K Iyer; Suvendu Purkait; Prashant Durgapal
Journal:  Cytojournal       Date:  2012-10-23       Impact factor: 2.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.